Norway vs Slovak Republic: Pharmaceutical consumption

Norway
342.2 Defined daily dose per 1 000 inhabitants per day
in 2025
Slovak Republic
284.4 Defined daily dose per 1 000 inhabitants per day
in 2024
Norway rank
8th
Slovak Republic rank
5th

Pharmaceutical consumption over time

  • Norway
  • Slovak Republic
0100200300400199520102025

How they compare

Norway currently reports 342.2 Defined daily dose per 1 000 inhabitants per day against 284.4 Defined daily dose per 1 000 inhabitants per day in Slovak Republic, a difference of 57.8 Defined daily dose per 1 000 inhabitants per day.

That makes Norway's figure about 1.2 times Slovak Republic's.

The two have swapped places 7 times across 26 shared years of data; in 1999 it was Slovak Republic ahead.

Norway ranks 8th and Slovak Republic ranks 5th of 21 countries.

Slovak Republic has averaged higher in every one of the 4 decades both report.

Head to head by decade

Decade Norway Slovak Republic Difference Ahead
1990s 198.5 Defined daily dose per 1 000 inhabitants per day 303.1 Defined daily dose per 1 000 inhabitants per day 104.6 Defined daily dose per 1 000 inhabitants per day Slovak Republic
2000s 253.24 Defined daily dose per 1 000 inhabitants per day 274.79 Defined daily dose per 1 000 inhabitants per day 21.55 Defined daily dose per 1 000 inhabitants per day Slovak Republic
2010s 266.63 Defined daily dose per 1 000 inhabitants per day 298.45 Defined daily dose per 1 000 inhabitants per day 31.82 Defined daily dose per 1 000 inhabitants per day Slovak Republic
2020s 299.94 Defined daily dose per 1 000 inhabitants per day 313.42 Defined daily dose per 1 000 inhabitants per day 13.48 Defined daily dose per 1 000 inhabitants per day Slovak Republic

Averages of every year both report within each decade.

Frequently asked questions

Which has higher pharmaceutical consumption, Norway or Slovak Republic?
Norway, at 342.2 Defined daily dose per 1 000 inhabitants per day against 284.4 Defined daily dose per 1 000 inhabitants per day in Slovak Republic as of 2025.
What is the difference in pharmaceutical consumption between Norway and Slovak Republic?
57.8 Defined daily dose per 1 000 inhabitants per day, with Norway ahead.
How many years of comparable data are there for Norway and Slovak Republic?
26 years are reported by both, from 1999 to 2024.
How do Norway and Slovak Republic rank globally for pharmaceutical consumption?
Norway ranks 8th and Slovak Republic ranks 5th of 21 countries.
Where does this data come from?
Organisation for Economic Co-operation and Development, published as Pharmaceutical consumption. Statizoid refreshes it automatically from the source and publishes the full history for both places.

Individual pages

Share, cite or embed this page

Cite this page

Norway vs Slovak Republic: Pharmaceutical consumption. Statizoid, drawing on Organisation for Economic Co-operation and Development. Retrieved 20 August 2026, from https://health.statizoid.com/compare/pharmaceutical-consumption/norway/slovak-republic-2/

Embed or link this data

Paste this into a page to link back to these figures. The data itself is free to reuse under OECD Terms and Conditions (attribution required); please keep the attribution.

<a href="https://health.statizoid.com/compare/pharmaceutical-consumption/norway/slovak-republic-2/">Norway vs Slovak Republic: Pharmaceutical consumption</a> — Statizoid

About this data

Indicator
Pharmaceutical consumption
Unit
Defined daily dose per 1 000 inhabitants per day
Source
Organisation for Economic Co-operation and Development
Licence
OECD Terms and Conditions (attribution required)
Coverage
31 places, 708 data points, 1980–2025
Last refreshed

Total pharmaceutical consumption according to the Anatomical Therapeutic Chemical (ATC) classification/Defined Daily Dose (DDD) system, created by the WHO Collaborating Centre for Drug Statistics Methodology. The unit of measurement is Defined Daily Dose (DDD), defined as the assumed average maintenance dose per day for a drug used on its main indication in adults. The Anatomical Therapeutic Chemical classification system divides drugs into different groups according to the organ system on which they act and/or therapeutical, pharmacological and chemical characteristics. The main principles for the classification of medicinal substances according to the ATC is presented in the publication “Guidelines for ATC classification and DDD assignment”, WHO Collaborating Centre for Drug Statistics Methodology, Oslo. The publication “ATC Index with DDDs” lists all assigned ATC codes and DDD values. Both these publications are updated annually. The ATC codes are based on the 2026 version of the ATC Index. All alterations implemented from January 2026 are available on the WHO Collaborating Centre for Drug Statistics Methodology website at https://www.whocc.no/lists_of__temporary_atc_ddds_and_alterations/. Data should reflect, where possible, the total consumption for each pharmaceutical drug category, i.e. including consumption in hospitals. Please refer to the Sources and Methods for detailed country-specific information.